Our goal at SCA Pharma always is to provide high quality products, service and value…
COVID-19 has transformed the delivery of health care in ways many of us could not have imagined. But as the crisis continues and evolves, it’s important we learn from early lessons COVID-19 taught us.
In a series of blogs and videos, senior leaders at SCA Pharma address the pandemic’s impact on quality, operations, product demand, and overall customer service during these challenging times.
First, CEO Milton Boyer describes his priorities for bolstering supply chains and satisfying customer needs. And he examines what a “new normal” might look like in our business moving forward.
You can download our updated list of medications to treat COVID-19 here.